ABSK021-301
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Abbisko Therapeutics Co. LTD.
Start Date
November 13, 2023
End Date
August 31, 2028
Administered By
Duke Cancer Institute
Awarded By
Abbisko Therapeutics Co. LTD.
Start Date
November 13, 2023
End Date
August 31, 2028